SEVENTY-FIVE CASES OF SOLID TUMOURS TREATED
.
In an effort to improve the generally disappointing results associated with single cytotoxic agents, intravenous injection of a combination of the 4 cytotoxic agents, cyclophosphamide, Methotrexate, Vincristine and 5-fluorouracil, originally advocated by Constanzi and Coltman (1969) In 3 patients with peripheral neuropathy Vinblastine was substituted for Vincristine in view of the known neurotoxic effect of the latter compound.
Three patients failed to complete their treatment because of side effects.
RESULTS
Breast Carcinoma (Table IV) These were patients with advanced and uncontrolled disease, which had previously been treated by hormones or adrenalectomy, and/or 5-fluorouracil or cyclophosphamide by injection. All cases showed some response; in 6 out of 14 this was complete and maintained for more than 6 months.
Subjective improvement was manifested by reliefofbone pain and improvement in general well-being. Objective remission was observed in chest wall recurrence (Fig. IA , B, C, D), in liver deposits and in pulmonary metastases.
In I patient lung function studies were carried out before and after 2 courses of chemotherapy. They showed an increase in total lung and initial residual capacity and in maximum expiratory flow rate (Table V, Fig. 2A, B) . Chest X-ray confirmed some clearing of disease.
Two patients were considered too ill for endocrine ablative procedure, but following good objective and subjective response to quadruple chemotherapy, successfully underwent bilateral adrenalectomy and oophorectomy. Remission continued without further chemotherapy in both cases.
Four patients with carcinoma en cuirasse were treated; I showed complete response and 3 partial response. In our experience this type of disease has proved unresponsive to single agent chemotherapy. (Fig. 3A, B Three cases of cancer of the cervix were also treated and failed to respond. Malignant melanoma (Table IX) Ten cases of malignant melanoma were treated without response, failing to substantiate the encouraging results suggested by Constanzi and Coltman (1969) . Seven patients survived for more than 6 months, but it is unlikely that quadruple chemotherapy altered the natural history of their disease. It could be argued that our modification of the dose regime contributed to these poor results, but our overall clinical impression is that this drug combination is of little value in malignant melanoma. 80ft tiSSU6 8arconm (Table X) The value of chemotherapy in soft tissue sarcoma is not generally recognised, although Wiltshaw (1967) has reported benefit following oral Methotrexate. Arterial infusion or perfusion may also produce regression in these lesions (Newton, 1967 (Table XI) Two patients with carcinoma of the stomach and 2 with carcinoma of the colon, and I with squamous carcinoma of the ano-rectal junction have been treated. AR showed some response; this was clinically complete in I case of carcinoma of the stomach who remained in remission for 3 months, eating normally and gaining weight. Barium meal examination showed reduction in size of the growth.
The patient with metastatic carcinoma of the ano-rectal junction is now in complete remission, 6 months after commencement of treatment. Miscellaneou8 (Table XII) No benefit followed treatment in the remainder of the series, which included patients with nephroblastoma, hepatoma and bone sarcoma.
DISCUSSION
Seventy-five patients have been treated by a modification of a regime originally reported by Constanzi and Coltman (1969) . This modification was necessary because of unacceptable toxicity in our earlier cases. Using the modified regime, treatment now present no undue problems of toxicity, yet still retains a therapeutic effect. It is practical to treat the majority of cases as out-patients. The most troublesomesideeffect(especiallyforfemalepatients)isalopecia,20%. Haemato- The success claimed by Constanzi and Coltman (1969) was not confirmed in this series of melanomas, and we no longer treat this tumour with the quadruple regime.
In a small group of 6 soft tissue sarcomata only I failed to respond. If in a larger series this response rate were to be maintained it would be an improvement on previous experience (Newton, 1967; Wiltshaw, 1967) .
In the small group of gastro-intestinal cancers, 4 out of 5 cases of carcinoma of the large bowel and stomach responded, and it is felt that where 5-fluorouracil has failed, quadruple chemotherapy may be of value. 
